Home › Compare › DMZPY vs JNJ

DMZPY vs JNJ: Dividend Comparison 2026

DMZPY yields 1.36% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DMZPY wins by $24.00 in total portfolio value
10 years
DMZPY
DMZPY
● Live price
1.36%
Share price
$6.35
Annual div
$0.09
5Y div CAGR
-37.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$1.22
Full DMZPY calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DMZPY vs JNJ

📍 DMZPY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDMZPYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DMZPY + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
DMZPY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DMZPY
Annual income on $10K today (after 15% tax)
$115.94/yr
After 10yr DRIP, annual income (after tax)
$1.04/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $702.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DMZPY + JNJ for your $10,000?

DMZPY: 50%JNJ: 50%
100% JNJ50/50100% DMZPY
Portfolio after 10yr
$20.0K
Annual income
$414.50/yr
Blended yield
2.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DMZPY
Analyst Ratings
1
Sell
Consensus: Sell
Altman Z
2.7
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DMZPY buys
0
JNJ buys
0
No recent congressional trades found for DMZPY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDMZPYJNJ
Forward yield1.36%3.36% ✓
Annual dividend / share$0.09$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR-37.7%5.8% ✓
Portfolio after 10y$20.0K$20.0K
Annual income after 10y$1.22$827.78 ✓
Total dividends collected$225.00 ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusSellBuy

Year-by-year: DMZPY vs JNJ ($10,000, DRIP)

YearDMZPY PortfolioDMZPY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,785$84.98$10,676$355.77+$109.00 → DMZPY
2$11,593$53.36$11,407$389.39+$186.00 → DMZPY
3$12,438$33.40$12,198$426.53+$240.00 → DMZPY
4$13,330$20.86$13,056$467.62+$274.00 → DMZPY
5$14,276$13.02$13,987$513.12+$289.00 → DMZPY
6$15,283$8.12$14,998$563.56+$285.00 → DMZPY
7$16,358$5.06$16,098$619.52+$260.00 → DMZPY
8$17,506$3.15$17,295$681.69+$211.00 → DMZPY
9$18,734$1.96$18,599$750.82+$135.00 → DMZPY
10$20,046$1.22$20,022$827.78+$24.00 → DMZPY

DMZPY vs JNJ: Complete Analysis 2026

DMZPY — Stock

Domino's Pizza Enterprises Limited operates retail food outlets. The company holds franchise rights for the Domino's brand in Australia, New Zealand, Belgium, France, the Netherlands, Japan, Germany, Luxembourg, Denmark, and Taiwan. It operates a network of approximately 2,949 stores. Domino's Pizza Enterprises Limited was incorporated in 1983 and is based in Brisbane, Australia.

Full DMZPY Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DMZPY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DMZPY vs SCHDDMZPY vs JEPIDMZPY vs ODMZPY vs KODMZPY vs MAINDMZPY vs ABBVDMZPY vs MRKDMZPY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.